
CPHI Pharma Award Winner: Drug Delivery, Devices, & Packaging
Terry Katz, CEO and cofounder of ForgeStop Technology Corporation, explains the company’s CPHI Award-winning connected product technology and how it helps to combat drug counterfeiting.
In October 2026, CPHI announced the winners of the
ForgeStop was forged when Katz, a nutraceutical brand owner, discovered his products had been counterfeited. Katz says he had assumed counterfeiting was a problem for luxury brands, not a small-to-medium supplement company. He could not find a protection service he trusted, so he and his co-founders built the first version of ForgeStop for his own products, letting consumers confirm authenticity before buying or taking them. The results led him to commercialize the technology. Currently, ForgeStop works across several industries, including pharmaceuticals worldwide.
Katz sees 2 tracks in fighting counterfeits. Enforcement, which large pharma companies’ brand protection teams handle well, only begins after an incident, and at worst patients get sicker or die. Authentication, ForgeStop’s focus, lets patients, pharmacists, and physicians verify a drug before it is prescribed or taken.
He argues that most authentication methods, including holograms, printed serialization, and QR codes, are print-based and so can be copied well enough to fool consumers, citing look-alike holograms sold online for half a cent each. ForgeStop instead uses the same NFC technology behind tap-to-pay, pairing a simple phone tap with high-level encryption on the back end.
Related to this article








